• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Celgene Corporation (CELG)

    -NasdaqGS
    117.18 Up 0.70(0.60%) Dec 19, 4:00PM EST
    |After Hours : 117.18 0.00 (0.00%) Dec 19, 7:31PM EST
    Add to Portfolio
    Prev Close:116.48
    Open:116.86
    Bid:109.37 x 800
    Ask:N/A
    1y Target Est:116.68
    Beta:2
    Next Earnings Date:29-Jan-15CELG Earnings announcement
    Day's Range:115.46 - 118.73
    52wk Range:66.85 - 119.84
    Volume:11,294,289
    Avg Vol (3m):5,216,990
    Market Cap:93.59B
    P/E (ttm):61.38
    EPS (ttm):1.91
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Headlines

    » More Headlines for CELG

    Comparison

    Symbol% ChgMkt Cap
    CELGUp 0.60%93.59B
    JNJDown 1.18%295.45B

    Key Statistics

    Forward P/E (1 yr):24.11
    P/S (ttm):12.67
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :3.68
    Quarterly EPS Est (Dec-14) :1.00
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):1.24

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback